Lower Response

Feb 18, 2021

Two new studies indicate that SARS-CoV-2 vaccines from Pfizer-BioNTech and Moderna elicit a lower neutralizing antibody responses against the B.1.351 viral lineage identified in South Africa, the Washington Post reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

Menu

Lower Response

To read the full story....

The Scan

COVAX's First Shipment

Support for Another

New Prototype Test

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

What's Popular?

WuXi Diagnostics Closes $150M Series B Financing Round

NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

Myriad Genetics Quarterly Revenues Decline 21 Percent

BioMérieux Reports 21 Percent Revenue Growth in Q4

Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

Sponsorships